Deep Blue Medical Advances

Deep Blue Medical Advances

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.deepbluemedical.com

Last Round

Series A

Apr 21, 2026

Total Funding Raised

$21.34M

Momentum Score

25 /100

Company Overview

Deep Blue Medical Advances is a medical device company that develops and commercializes surgical products for hernia repair and other soft tissue surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hernia repairsurgical meshsoft tissue surgeryMedTechT-Line Hernia Meshmesh anchoringventral hernia repairsurgical implantscheesewiring preventionmedical devicesfixation failureFDA 510(k) clearancepolypropylene meshumbilical hernia repairbreast surgery scaffold

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Blue Medical Advances Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deep Blue Medical Advances Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 21, 2026
VC RoundSep 5, 2024
Series AJun 28, 2022
Series AFeb 4, 2021
DebtJan 8, 2021
Series A
Jun 21, 2019

Key People

Founding team and executive leadership

Howie Levinson

Founder Chief Medical Officer

Founding Team

Bill Perry

CEO, Board Member

Executive Team

Deep Blue Medical Advances Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Raised $6M in Series A funding.

  • Apr 21, 2026

    Preparing for commercial launch of flagship soft tissue repair platform.

Deep Blue Medical Advances Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deep Blue Medical Advances Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deep Blue Medical Advances's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range11
Year Founded2015
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.